留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肺移植围手术期体外膜肺氧合应用指南(2019版)

中华医学会器官移植学分会 国家肺移植质量管理与控制中心

中华医学会器官移植学分会, 国家肺移植质量管理与控制中心. 肺移植围手术期体外膜肺氧合应用指南(2019版)[J]. 器官移植, 2019, 10(4): 402-409. doi: 10.3969/j.issn.1674-7445.2019.04.009
引用本文: 中华医学会器官移植学分会, 国家肺移植质量管理与控制中心. 肺移植围手术期体外膜肺氧合应用指南(2019版)[J]. 器官移植, 2019, 10(4): 402-409. doi: 10.3969/j.issn.1674-7445.2019.04.009
Branch of Organ Transplantation of Chinese Medical Association, National Quality Management and Control Center for Lung Transplantation. Guideline on the application of extracorporeal membrane oxygenation during the perioperative period of lung transplantation(2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(4): 402-409. doi: 10.3969/j.issn.1674-7445.2019.04.009
Citation: Branch of Organ Transplantation of Chinese Medical Association, National Quality Management and Control Center for Lung Transplantation. Guideline on the application of extracorporeal membrane oxygenation during the perioperative period of lung transplantation(2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(4): 402-409. doi: 10.3969/j.issn.1674-7445.2019.04.009

肺移植围手术期体外膜肺氧合应用指南(2019版)

doi: 10.3969/j.issn.1674-7445.2019.04.009
基金项目: 

江苏省科教强卫项目 JCRCB2016003

无锡市卫计委科研重大项目 Z201801

详细信息
    通讯作者:

    陈静瑜,男,1963年生,主任医师,研究方向为肺移植,Email:chenjy@wuxiph.com

  • 中图分类号: R617, R563

Guideline on the application of extracorporeal membrane oxygenation during the perioperative period of lung transplantation(2019 edition)

  • 摘要: 肺移植是治疗多种终末期肺疾病的唯一有效方法,体外膜肺氧合(ECMO)在肺移植围手术期起到重要的桥接和支持作用。本指南从肺移植术前ECMO的桥接治疗、术中的心肺支持及术后功能维持等方面,总结肺移植临床实践经验,以期为我国肺移植相关临床科室提供工作指引。

     

  • 图  1  ECMO双极静脉插管示意图[1]

    Figure  1.  Schematic diagram of ECMO bipolar venous intubation

  • [1] LOOR G, SIMPSON L, PARULEKAR A. Bridging to lung transplantation with extracorporeal circulatory support: when or when not?[J]. J Thorac Dis, 2017, 9(9):3352-3361. DOI: 10.21037/jtd.2017.08.117.
    [2] KEARNS SK, HERNANDEZ OO. "Awake" extracorporeal membrane oxygenation as a bridge to lung transplant[J]. AACN Adv Crit Care, 2016, 27(3):293-300. doi: 10.4037/aacnacc2016792
    [3] HAKIM AH, AHMAD U, MCCURRY KR, et al. Contemporary outcomes of extracorporeal membrane oxygenation used as bridge to lung transplantation[J]. Ann Thorac Surg, 2018, 106(1):192-198. DOI: 10.1016/j.athoracsur.2018.02.036.
    [4] LEE SG, SON BS, KANG PJ, et al. The feasibility of extracorporeal membrane oxygenation support for inter-hospital transport and as a bridge to lung transplantation[J]. Ann Thorac Cardiovasc Surg, 2014, 20(1):26-31. doi: 10.5761/atcs.oa.12.00203
    [5] 龙村.体外膜肺氧合循环支持专家共识[J].中国体外循环杂志, 2014, 12(2):65-67. DOI: 10.13498/j.cnki.chin.j.ecc.2014.02.01.

    LONG C. Expert consensus on extracorporeal membrane oxygenation circulation support[J]. Chin J Extra Circ, 2014, 12(2):65-67.DOI: 10.13498/j.cnki.chin.j.ecc.2014.02.01.
    [6] REEB J, OLLAND A, RENAUD S, et al. Vascular access for extracorporeal life support: tips and tricks[J]. J Thorac Dis, 2016, 8(Suppl 4):S353-S363. DOI: 10.21037/jtd.2016.04.42.
    [7] DOUFLÉ G, FERGUSON ND. Monitoring during extracorporeal membrane oxygenation[J]. Curr OpinCrit Care, 2016, 22(3):230-238. DOI: 10.1097/MCC.0000000000000309.
    [8] LUYT CE, BRÉCHOT N, DEMONDION P, et al. Brain injury during venovenous extracorporeal membrane oxygenation[J]. Intensive Care Med, 2016, 42(5):897-907. DOI: 10.1007/s00134-016-4318-3.
    [9] CHEN H, YU RG, YIN NN, et al. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review[J]. Crit Care, 2014, 18(6):675. DOI: 10.1186/s13054-014-0675-x.
    [10] GARCIA JP, KON ZN, EVANS C, et al. Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls[J]. J Thorac Cardiovasc Surg, 2011, 142(4):755-761. DOI: 10.1016/j.jtcvs.2011.07.029.
    [11] IUS F, SOMMER W, TUDORACHE I, et al. Veno-veno-arterial extracorporeal membrane oxygenation for respiratory failure with severe haemodynamic impairment: technique and early outcomes[J]. Interact Cardiovasc Thorac Surg, 2015, 20(6):761-767. DOI: 10.1093/icvts/ivv035.
    [12] PARK BW, LEE SR, LEE MH, et al. Short stature is associated with the development of lower limb ischaemia during extracorporeal life support[J]. Perfusion, 2018, 33(5):383-389. DOI: 10.1177/0267659118755273.
    [13] MCRAE K, DE PERROT M. Principles and indications of extracorporeal life support in general thoracic surgery[J]. J Thorac Dis, 2018, 10(Suppl 8):S931-S946. DOI: 10.21037/jtd.2018.03.116.
    [14] PORTEOUS MK, LEE JC. Primary graft dysfunction after lung transplantation[J]. Clin Chest Med, 2017, 38(4):641-654. DOI: 10.1016/j.ccm.2017.07.005.
    [15] MULVIHILL MS, YEROKUN BA, DAVIS RP, et al. Extracorporeal membrane oxygenation following lung transplantation: indications and survival[J]. J Heart Lung Transplant, 2017: S1053-2498(17)31880-6. DOI: 10.1016/j.healun.2017.06.014.
    [16] SHARGALL Y, GUENTHER G, AHYA VN, et al. Report of the ISHLT Working Group on primary lung graft dysfunction part Ⅵ: treatment[J]. J Heart Lung Transplant, 2005, 24(10):1489-1500. doi: 10.1016/j.healun.2005.03.011
    [17] BRODIE D, BACCHETTA M. Extracorporeal membrane oxygenation for ARDS in adults[J]. N Engl J Med, 2011, 365(20):1905-1914. DOI: 10.1056/NEJMct1103720.
    [18] GULACK BC, HIRJI SA, HARTWIG MG. Bridge to lung transplantation and rescue post-transplant: the expanding role of extracorporeal membrane oxygenation[J]. J Thorac Dis, 2014, 6(8):1070-1079. DOI: 10.3978/j.issn.2072-1439.2014.06.04.
    [19] CASTLEBERRY AW, HARTWIG MG, WHITSON BA. Extracorporeal membrane oxygenation post lung transplantation[J]. Curr Opin Organ Transplant, 2013, 18(5):524-530. DOI: 10.1097/MOT.0b013e328365197e.
    [20] ABRAMS D, BRODIE D, ARCASOY SM. Extracorporeal life support in lung transplantation[J]. Clin Chest Med, 2017, 38(4):655-666. DOI: 10.1016/j.ccm.2017.07.006.
    [21] MULLA H, LAWSON G, VON ANREP C, et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation[J]. Perfusion, 2000, 15(1):21-26. doi: 10.1177/026765910001500104
    [22] AHSMAN MJ, HANEKAMP M, WILDSCHUT ED, et al. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates[J]. Clin Pharmacokinet, 2010, 49(6):407-419. DOI: 10.2165/11319970-000000000-00000.
    [23] WAGNER D, PASKO D, PHILLIPS K, et al. In vitro clearance of dexmedetomidine in extracorporeal membrane oxygenation[J]. Perfusion, 2013, 28(1):40-46. DOI: 10.1177/0267659112456894.
    [24] SHEKAR K, ROBERTS JA, MULLANY DV, et al. Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure[J]. Anaesth Intensive Care, 2012, 40(4):648-655. doi: 10.1177/0310057X1204000411
    [25] HA MA, SIEG AC. Evaluation of altered drug pharmacokinetics in critically Ill adults receiving extracorporeal membrane oxygenation[J]. Pharmacotherapy, 2017, 37(2):221-235. DOI: 10.1002/phar.1882.
    [26] ABRAMS D, JAVIDFAR J, FARRAND E, et al. Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study[J]. Crit Care, 2014, 18(1):R38. DOI: 10.1186/cc13746.
    [27] KO Y, CHO YH, PARK YH, et al. Feasibility and safety of early physical therapy and active mobilization for patients on extracorporeal membrane oxygenation[J]. ASAIO J, 2015, 61(5):564-568. DOI: 10.1097/MAT.0000000000000239.
    [28] LINKINS LA, DANS AL, MOORES LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(2 Suppl):e495S-e530S. DOI: 10.1378/chest.11-2303.
    [29] MARASCO SF, LUKAS G, MCDONALD M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients[J]. Heart Lung Circ, 2008, 17 (Suppl 4):S41-S47. DOI: 10.1016/j.hlc.2008.08.009.
    [30] AISSAOUI N, EL-BANAYOSY A, COMBES A. How to wean a patient from veno-arterial extracorporeal membrane oxygenation[J]. Intensive Care Med, 2015, 41(5):902-905. DOI: 10.1007/s00134-015-3663-y.
    [31] AISSAOUI N, LUYT CE, LEPRINCE P, et al. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock[J]. Intensive Care Med, 2011, 37(11):1738-1745. DOI: 10.1007/s00134-011-2358-2.
    [32] MENAKER J, TABATABAI A, RECTOR R, et al. Incidence of cannula-associated deep vein thrombosis after veno-venous extracorporeal membrane oxygenation[J]. ASAIO J, 2017, 63(5):588-591. DOI: 10.1097/MAT.0000000000000539.
  • 加载中
图(1)
计量
  • 文章访问数:  218
  • HTML全文浏览量:  10
  • PDF下载量:  25
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-05-23
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2019-07-15

目录

    /

    返回文章
    返回